Mirae Asset Global Etfs Holdings Ltd. Tg Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 82,647 shares of TGTX stock, worth $2.09 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
82,647Holding current value
$2.09 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TGTX
# of Institutions
287Shares Held
91.8MCall Options Held
1.9MPut Options Held
1.45M-
Vanguard Group Inc Valley Forge, PA13.7MShares$346 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$288 Million0.0% of portfolio
-
State Street Corp Boston, MA6.7MShares$169 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.65MShares$92.1 Million6.57% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V83.24MShares$81.9 Million0.07% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $3.67B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...